anti-PD1 treatmentimmune checkpoint therapyTNG260pembrolizumab
…t CoREST inhibition by TNG260 sensitizes STK11-mutant tumors to anti-PD1 treatment. TNG260, in combination with pembrolizumab, is being evaluated …
7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed
All extracted treatments
Showing 2,761–2,820 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
active TB treatment1active cancer treatment1active control-assisted integrated exposure therapy1active medical treatments1active monitoring1active resuscitation1active sodium correction1active tDCS-sham TMS1activity modification1acupoint catgut embedding1acupoint therapies1acupressure1acupuncturerelated1acupuncturespecific1acute haemodialysis1acute lymphoblastic leukaemia–type multi-agent chemotherapy1acute non-invasive ventilation1acute pain management1acute stroke management1acute treatments1add-on treatment1additional medications1adeno-associated virus-based gene replacement therapy1adjunct immunosuppressive/biologic therapy1adjunct therapies1adjunctive dopaminergic therapies1adjunctive treatments1adjuvant chemoimmunotherapy1adjuvant chemoradiotherapy1adjuvant concurrent chemoradiation1adjuvant immunotherapies1adjuvant or neoadjuvant chemotherapy1adjuvant radiochemotherapy1adoptive cellular therapies1adoptive cellular therapy1adoptive immunotherapies1adrenalectomy1adrenaline injection1adrenoceptor-targeting agents1adulticide fogging1advanced cardiovascular management1advanced combination therapy1advanced prehospital care1advanced therapy231advanced treatment1advanced treatments1agents promoting erythroid maturation1aggressive treatments1airway stabilisation1alkylating chemotherapy1allergic response modulating therapies1allogeneic haematopoietic stem cell transplantation1allogeneic hematopoietic stem cell transplantation1allogeneic peripheral blood stem cell transplant1allogeneic stem cell transplant1allogeneic stem cell transplantation1allogeneic therapy1allografts1alternative therapeutic interventions1alternative therapies1
Articles mentioning treatments
7,227 articles · page 231 of 603lymphodepleting chemotherapyAGX-148oral head and neck squamous cell carcinomamelanomathyroid cancersolid tumorsProvidence Institutional Review BoardClinicalTrials.gov
…ard and experimental therapies. Patients undergo tumor harvest, lymphodepleting chemotherapy, adoptive transfer of AGX-148 and high-dose IL-2 for one week, …
immunotherapyNanO 2Glioblastoma MultiformeNanO2PaclitaxelTNBCTriple-negative breast cancerDOD GrantBALB/c mice
… experiments, we tested the effect of NanO2 in combination with immunotherapy (IT), chemotherapy (CTX, paclitaxel) or both IT and CTX. BALB/c…
Triplet therapyanthracycline chemotherapyFTY720Flt3LTNBCDoxil D1NCT05029999
…s) as well as by blocking lymphocyte egress with FTY720.Results Triplet therapy significantly delayed tumor progression and extended median sur…
immunotherapyBreast cancerQUICKARRAYS, Inc
…y mapped the TME to identify features potentially predictive of immunotherapy response. FFPE (Formalin-Fixed Paraffin-Embedded) tissue slide …
T-FUSUniversity of Virginiacancerbreast cancerBCNIH DP5OD031846αCD40
…t of CD4+ T cells following rechallenge (figure 2O).Conclusions T-FUS+αCD40 represents a novel paradigm for immunotherapy of BC-capab…
anti-PD-1 therapyPD-1 therapyMD Anderson Cancer CenterKAN-001non-small cell lung cancerNSCLCCRCHUMCanadian Council
… evaluated in the MCA205 murine tumor model in combination with anti-PD-1 therapy. Comparative arms included treatment with FMT from ICI-non-resp…
immune checkpoint blockadeHER2-targeted therapyLeica BiosystemsIndica Labsgastric and gastroesophageal junction (GEJ) adenocarcinomaHER2-amplified colorectal cancerHER2-low breast cancerHER2-positive breast cancer
…, suggesting possible synergy between HER2-targeted therapy and immune checkpoint blockade.In HER2-amplified colorectal cancer, PD-L1 expression and immun…
immunotherapychemotherapyMassachusetts General HospitalMGH Histopathology Research CoreTNBCImmunomedics/GileadSacituzumab govitecantriple-negative breast cancerhuman breast cancer
…ody drug conjugates to activate anti-tumor immunity and enhance immunotherapy response.Acknowledgements We gratefully acknowledge Immunomedic…
Adoptive CTL therapyimmunotherapymelanoma-specificExtramammary Paget’s disease (EMPD)IL-2EMPDmelanomaRadiother Oncolsolid tumorsEBV-related cancers+1 more
…es in solid tumors, yet limited data exist in the EMPD context. Adoptive CTL therapy, which involves the ex vivo expansion and activation of autolog…
ImmunotherapyAzaAzacytidineAMLAcute Myeloid Leukemia
… AML has remained largely unchanged over the last four decades. Immunotherapy is a promising therapy in many cancers including AML. T cell ex…
immunotherapyEwing SarcomaChildren’s Oncology GroupIL1RAP
…on of the immune environment in ES may reveal the blockades for immunotherapy efforts and potential new pathways to be exploited in the futur…